Akebia Therapeutics (AKBA) Treasury Shares (2013 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Treasury Shares of $162000.0 for Q1 2016, up 0.62% year-over-year from $161000.0 in Q2 2015, and little changed quarter-over-quarter from $162000.0 in Q4 2015.
Akebia Therapeutics (AKBA) Treasury Shares (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Treasury Shares for 3 consecutive years, with $162000.0 the latest figure, recorded in Q1 2016.
- In Q1 2016, Treasury Shares rose 0.62% year-over-year to $162000.0; the TTM figure through Mar 2016 stood at $162000.0 (up 0.62% YoY), while the FY2015 annual figure was $162000.0, up 72.34% from the prior year.
- Treasury Shares steadied at $162000.0 in Q1 2016 per AKBA's latest filing, from $162000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $9.1 million in Q1 2026 and bottomed at $330622.0 in Q4 2025.
- Historically, Treasury Shares has averaged $3.8 million across 5 years, with a median of $3.3 million in 2023.
- Annual changes were most pronounced in 2015 — Treasury Shares surged 658.36% — and 2016, when it grew 0.62%.
- Akebia Therapeutics' Treasury Shares stood at $94000.0 in 2014, then jumped by 72.34% to $162000.0 in 2015, then changed by 0.0% to $162000.0 in 2016.
- Business Quant data shows AKBA's Treasury Shares at $162000.0 in Q1 2016, $162000.0 in Q4 2015, and $162000.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 19.00 Mn |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.10 Mn |
| Jun 30, 2026 | 8.10 Mn |
| Mar 31, 2026 | 9.08 Mn |
| Mar 31, 2026 | 9.08 Mn |
| Dec 31, 2025 | 330,622.00 |
| Dec 31, 2025 | 330,622.00 |
| Sep 30, 2025 | 6.24 Mn |
| Sep 30, 2025 | 6.24 Mn |
| Jun 30, 2025 | 6.44 Mn |
| Jun 30, 2025 | 6.44 Mn |
| Mar 31, 2025 | 741,969.00 |
| Mar 31, 2025 | 741,969.00 |
| Dec 31, 2024 | 4.11 Mn |
| Dec 31, 2024 | 4.11 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Mar 31, 2024 | 2.07 Mn |